Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up-Reference-Cited by-同舟云学术

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Published:2014-12 Issue:9959 Volume:384 Page:2027-2035
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Schröder Fritz H,Hugosson Jonas,Roobol Monique J,Tammela Teuvo L J,Zappa Marco,Nelen Vera,Kwiatkowski Maciej,Lujan Marcos,Määttänen Liisa,Lilja Hans,Denis Louis J,Recker Franz,Paez Alvaro,Bangma Chris H,Carlsson Sigrid,Puliti Donella,Villers Arnauld,Rebillard Xavier,Hakama Matti,Stenman Ulf-Hakan,Kujala Paula,Taari Kimmo,Aus Gunnar,Huber Andreas,van der Kwast Theo H,van Schaik Ron H N,de Koning Harry J,Moss Sue M,Auvinen Anssi

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Screening and prostate-cancer mortality in a randomized European study;Schröder;N Engl J Med,2009

2. Prostate-cancer mortality at 11 years of follow-up;Schröder;N Engl J Med,2012

3. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer;Draisma;J Natl Cancer Inst,2003

4. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management;Cooperberg;J Clin Oncol,2004

5. Quality-of-life effects of prostate-specific antigen screening;Heijnsdijk;N Engl J Med,2012

Cited by 1261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Screening: Theory and Applications;International Encyclopedia of Public Health;2025

2. National Trends in PSA Cancer Screening With Parallel Investigation of Colorectal Cancer Screening: An Analysis of the CDC Behavioral Risk Factor Surveillance System From 2012 to 2022;Clinical Genitourinary Cancer;2024-12

3. PSA, an outdated biomarker for prostate cancer: In search of a more specific biomarker, citrate takes the spotlight;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

4. Long acting injectables for the treatment of prostate cancer;Journal of Drug Delivery Science and Technology;2024-10

5. Multiparametric magnetic resonance imaging and magnetic resonance imaging fusion-guided biopsy for the diagnosis of prostate cancer: current status;Digital Diagnostics;2024-09-11